These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 29193801)

  • 21. Projecting the future burden of cancer: Bayesian age-period-cohort analysis with integrated nested Laplace approximations.
    Riebler A; Held L
    Biom J; 2017 May; 59(3):531-549. PubMed ID: 28139001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bayesian network meta-regression hierarchical models using heavy-tailed multivariate random effects with covariate-dependent variances.
    Li H; Lim D; Chen MH; Ibrahim JG; Kim S; Shah AK; Lin J
    Stat Med; 2021 Jul; 40(15):3582-3603. PubMed ID: 33846992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fast and flexible inference for joint models of multivariate longitudinal and survival data using integrated nested Laplace approximations.
    Rustand D; van Niekerk J; Krainski ET; Rue H; Proust-Lima C
    Biostatistics; 2024 Apr; 25(2):429-448. PubMed ID: 37531620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spatial and spatio-temporal models with R-INLA.
    Blangiardo M; Cameletti M; Baio G; Rue H
    Spat Spatiotemporal Epidemiol; 2013 Mar; 4():33-49. PubMed ID: 23481252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Laplacian-P-splines for Bayesian inference in the mixture cure model.
    Gressani O; Faes C; Hens N
    Stat Med; 2022 Jun; 41(14):2602-2626. PubMed ID: 35699121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accounting for individual-specific variation in habitat-selection studies: Efficient estimation of mixed-effects models using Bayesian or frequentist computation.
    Muff S; Signer J; Fieberg J
    J Anim Ecol; 2020 Jan; 89(1):80-92. PubMed ID: 31454066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A tutorial on spatio-temporal disease risk modelling in R using Markov chain Monte Carlo simulation and the CARBayesST package.
    Lee D
    Spat Spatiotemporal Epidemiol; 2020 Aug; 34():100353. PubMed ID: 32807395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bayesian explanatory additive IRT models.
    Mair P; Gruber K
    Br J Math Stat Psychol; 2022 Feb; 75(1):59-87. PubMed ID: 34089620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. crossnma: An R package to synthesize cross-design evidence and cross-format data using network meta-analysis and network meta-regression.
    Hamza T; Schwarzer G; Salanti G
    BMC Med Res Methodol; 2024 Aug; 24(1):169. PubMed ID: 39103781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Network meta-analysis: development of a three-level hierarchical modeling approach incorporating dose-related constraints.
    Owen RK; Tincello DG; Keith RA
    Value Health; 2015 Jan; 18(1):116-26. PubMed ID: 25595242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An empirical comparison of Bayesian modelling strategies for missing binary outcome data in network meta-analysis.
    Spineli LM
    BMC Med Res Methodol; 2019 Apr; 19(1):86. PubMed ID: 31018836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bayesian one-step IPD network meta-analysis of time-to-event data using Royston-Parmar models.
    Freeman SC; Carpenter JR
    Res Synth Methods; 2017 Dec; 8(4):451-464. PubMed ID: 28742955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hierarchical Bayesian approaches for detecting inconsistency in network meta-analysis.
    Zhao H; Hodges JS; Ma H; Jiang Q; Carlin BP
    Stat Med; 2016 Sep; 35(20):3524-36. PubMed ID: 27037506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implementing informative priors for heterogeneity in meta-analysis using meta-regression and pseudo data.
    Rhodes KM; Turner RM; White IR; Jackson D; Spiegelhalter DJ; Higgins JP
    Stat Med; 2016 Dec; 35(29):5495-5511. PubMed ID: 27577523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing the convergence of Markov Chain Monte Carlo methods: an example from evaluation of diagnostic tests in absence of a gold standard.
    Toft N; Innocent GT; Gettinby G; Reid SW
    Prev Vet Med; 2007 May; 79(2-4):244-56. PubMed ID: 17292499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Gibbs-INLA algorithm for multidimensional graded response model analysis.
    Lin X; Zhang S; Tang Y; Li X
    Br J Math Stat Psychol; 2024 Feb; 77(1):169-195. PubMed ID: 37772696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimating multilevel regional variation in excess mortality of cancer patients using integrated nested Laplace approximation.
    Seppä K; Rue H; Hakulinen T; Läärä E; Sillanpää MJ; Pitkäniemi J
    Stat Med; 2019 Feb; 38(5):778-791. PubMed ID: 30334278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adaptive prior weighting in generalized regression.
    Held L; Sauter R
    Biometrics; 2017 Mar; 73(1):242-251. PubMed ID: 27192504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Bayesian approach to discrete multiple outcome network meta-analysis.
    Graziani R; Venturini S
    PLoS One; 2020; 15(4):e0231876. PubMed ID: 32343711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using Generalized Linear Mixed Models to Evaluate Inconsistency within a Network Meta-Analysis.
    Tu YK
    Value Health; 2015 Dec; 18(8):1120-5. PubMed ID: 26686799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.